Table 1.

Women excluded or withdrawn from the study.

Women excluded from the study	Vagitocin 400 IU n = 24	Vagitocin 100 IU n = 24	Placebo n = 16	Total number
Superficial cells >5% at V1	3	1	0	4
Abnormal endometrial biopsy	1	0	0	1
Withdrawal of consent	2	0	0	2
Adverse events	1a	1b	1c	3
Total number of women who did not finalise the study	7	2	1	10

Note: The table shows the number of randomised women in the different treatment groups who did not finalise the study because they (1) did not fulfil the inclusion criteria, (2) withdrew their consent or (3) experienced adverse events.

^aHeadache, ^bExperience of illness, ^cPalpitations.